(2023). Development of an Asthma Exacerbation Risk Prediction Model for Conversational Use by Adults in England. Pragmat Obs Res, 14, 111-125. http://doi.org/10.2147/por.s424098.
(2023). Prevalence of Poorly Controlled Asthma and Factors Associated with Specialist Referral in Those with Poorly Controlled Asthma in a Paediatric Asthma Population. J Asthma Allergy, 16, 1065-1075. http://doi.org/10.2147/jaa.s428623.
(2023). Online Survey to Investigate Asthma Medication Prescription and Adherence from the Perspective of Patients and Healthcare Practitioners in England. J Asthma Allergy, 16, 987-996. http://doi.org/10.2147/jaa.s426227.
(2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 2039-2054. http://doi.org/10.2147/copd.s408688.
(2023). Determining prescriptions in electronic healthcare record data: methods for development of standardized, reproducible drug codelists. Jamia Open, 6, ooad078. http://doi.org/10.1093/jamiaopen/ooad078.
(2023). Recent trends in asthma diagnosis, preschool wheeze diagnosis and asthma exacerbations in English children and adolescents: a SABINA Jr study. Thorax. http://doi.org/10.1136/thorax-2022-219757.
(2023). Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England. Bmc Pulm Med, 23, 256. http://doi.org/10.1186/s12890-023-02550-0.
(2023). Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 1431-1444. http://doi.org/10.2147/copd.s411437.
(2023). Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019. Int J Chron Obstruct Pulmon Dis, 18, 1565-1574. http://doi.org/10.2147/copd.s411739.
(2023). Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England. Thorax. http://doi.org/10.1136/thorax-2022-219320.